Thymocyte development in Ah-receptor-deficient mice is refractory to TCDD-inducible changes

International Journal of Immunopharmacology

Volumn 21, Issue 12, 1999, Pages 841-859

  Hundeiker, C ^a   Pineau, T ^b   Cassar, G ^c   Betensky, R A ^d   Gleichmann, E ^a   Esser, C ^a  

^a Med Inst of Environmental Hygiene   (Germany)

^b CEMAGREF   (France)

^c CHU PURPAN   (France)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

2; 3; 7; 8 tetrachlorodibenzo p dioxin; Ah receptor; CD44; Fetal thymus development; Knockout mouse; Thymus emigrants

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CYTOTOXICITY; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE;

ANIMALS; ANTIGENS, CD44; ATROPHY; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; ORGAN CULTURE TECHNIQUES; RECEPTORS, ARYL HYDROCARBON; T-LYMPHOCYTE SUBSETS; TETRACHLORODIBENZODIOXIN; THYMUS GLAND; XENOBIOTICS;

EID: 0032760628     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00053-3     Document Type: Article

References (52)

1. Andreola F., Fernandez-Salguero P.M., Chiantore M.V., Petkovich M.P., Gonzalez F.J., Delva N. Aryl hydrocarbon receptor knockout mice (AHR -/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 57:1997;2835-2838.
2. Antoch M.P., Song E.J., Chang A.M., Vitaterna M.H., Zhao Y., Wilsbacher L.D., Sangoram A.M., King D.P., Pinto L.H., Takahashi J.S. Functional identification of the mouse circadian clock gene by transgenic BAC rescue. Cell. 89:1997;655-667.
3. Burbach K.M., Poland A., Bradfield C.A. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA. 89:1992;8185-8189.
4. Buu-Hoi N.P., Chan P.H., Sesque G., Azum-Gelade M.C., Saint-Ruf G. Organs as targets of 'dioxin' (2,3,7,8-tetrachlorodibenzo-p-dioxin) intoxication. Naturwissenschaften. 58:1972;174-175.
5. Carlstedt-Duke J.M.B. Tissue distribution of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Cancer Res. 39:1979;3172-3176.
6. Choi E.J., Toscano D.G., Ryan J.A., Riedel N., Toscano W.A.J. Dioxin induces transforming growth factor-alpha in human keratinocytes. J. Biol. Chem. 266:1991;9591-9597.
7. Crews S.T., Thomas J.B., Goolman C.S. The Drosophila single-minded gene encodes a nuclear protein with sequence similarity to the per gene product. Cell. 52:1988;143-151.
8. Cuthill S., Wilhelmsson A., Poellinger L. Role of the ligand in intracellular receptor function: receptor affinity determines activation in vitro of the latent dioxin receptor to a DNA-binding form. Mol. Cell. Biol. 11:1991;401-411.
9. Dahmane N., Charron G., Lopes C., Yaspo M-L., Maunoury C., Decorte L., Sinet P-M., Bloch B., Delabar J-M. Down syndrome-critical region contains a gene homologous to Drosophila sim expressed during rat and human central nervous system development. Proc. Natl. Acad. Sci. USA. 92:1995;9191-9195.
10. Deluca D., Bluestone J.A., Shultz L.D., Sharrow S.O., Tatsumi Y. Programmed differentiation of murine thymocytes during fetal thymus organ culture. J. Immunol. Methods. 178:1995;13-29.
11. Ema M., Sogawa K., Watanabe N., Chujoh Y., Matsushita N., Gotoh O., Funae Y., Fujii Kuriyama Y. cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184:1992;246-253.
12. Esser C., Welzel M. Ontogenic development of murine fetal thymocytes is accelerated by 3,3′,4,4′-tetrachlorobiphenyl. Int. J. Immunopharmacol. 15:1993;841-852.
13. Fernandez-Salguero P.M., Pineau T., Hilbert D.M., McPhail T., Lee S.S.T., Kimura S., Nebert D.W., Rudikoff S., Ward J.M., Gonzales F.J. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science. 268:1995;722-726.
14. Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140:1996;173-179.
15. Haas W., Tonegawa S. Development and selection of gamma-delta T cells. Curr. Opinion Immunol. 4:1992;147-155.
16. Hahn M.E., Karchner S.I., Shapiro M.A., Perera S.A. Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AHR1 and AHR2) and the PAS family. Proc. Natl. Acad. Sci. 94:1997;13743-13748.
17. Hankinson O. The aryl hydrocarbon receptor complex. Ann. Rev. Pharmacol. Toxicol. 35:1995;307-340.
18. Haynes B.F., Telen M.J., Hale L.P., Denning S.M. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today. 10:1989;423-428.
19. Haynes B.F., Telen M.J., Hale L.P., Denning S.M. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today. 10:1989;423-428.
20. Hoffer A., Chang C.Y., Puga A. Dioxin induces transcription of fos and jun genes by Ah receptor- dependent and -independent pathways. Toxicol. Appl. Pharmacol. 141:1996;238-247.
21. Holsapple M.P., Snyder N.K., Wood S.C., Morris D.L. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology. 69:1991;219-255.
22. Itohara S., Nakanishi N., Kanagawa O., Kubo R., Tonegawa S. Monoclonal antibodies specific to native murine T-cell receptor gamma delta: analysis of gamma delta T cells during thymic ontogeny and in peripheral lymphoid organs. Proc. Natl. Acad. Sci. USA. 86:1989;5094-5098.
23. Jackson F.R., Bargiello T.A., Yun S.H., Young M.W. Product of the per locus of Drosophila shares homology with proteoglycans. Nature. 320:1986;185-188.
24. Kamath A.B., Nagarkatti P.S., Nagarkatti M. Characterization of phenotypic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo and its effect on apoptosis. Toxicol. Appl. Pharmacol. 150:1998;117-124.
25. Kleinbaum D.G., Kupper L.L., Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. 1982;Wadsworth Inc, Belmont, CA, USA.
26. Kremer J., Gleichmann E., Esser C. Thymic stroma exposed to arylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation. J. Immunol. 153:1994;2778-2786.
27. Kremer J., Lai Z-W., Esser C. Evidence for the promotion of positive selection of thymocytes by Ah receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin. Eur. J. Pharmacol. 293:1995;413-427.
28. Kronenberg S., Lai Z-W., Esser C. 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to development of mature CD8 cells in MHC-I deficient mice. Organohalogen Comp. 34:1997;104-107.
29. Lai Z-W., Kremer J., Gleichmann E., Esser C. 3,3′4,4′-tetrachlorobiphenyl inhibits proliferation of immature thymocytes in fetal thymus organ culture. Scand. J. Immunol. 39:1994;480-488.
30. Lai Z-W., Griem P., Gleichmann E., Esser C. CD8 thymocytes derived from 3,3′,4,4′-tetrachlorobiphenyl-exposed fetal thymi possess killing activity. Toxicol. Appl. Pharmacol. 133:1995;223-232.
31. Lai Z-W., Pineau T., Esser C. Identification of dioxin-responsive elements (DREs) in the 5′ regions of putative dioxin-inducible genes. Chemico-Biol. Interactions. 100:1996;97-112.
32. Lai Z-W., Hundeiker C., Gleichmann E., Esser C. Cytokine gene expression during ontogeny in murine thymus upon activation of the Ah receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 52:1997;30-37.
33. Li W., Donat S., Döhr O., Unfried K., Abel J. Ah receptor in different tissues of C57BL/6J and DBA/2J mice: use of competitive polymerase chain reaction to measure Ah-receptor mRNA expression. Arch. Biochem. Biophys. 315:1994;279-284.
34. Lusska A.E., Shen E., Whitlock J.P. Jr. Protein-DNA interactions at a dioxin-responsive enhancer: analysis of six bona fide DNA-binding sites for the liganded Ah-receptor. J. Biol. Chem. 268:1993;6575-6580.
35. Okey A.B., Riddick D.S., Harper P.A. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. TiPS. 15:1994;226-232.
36. O'Neill H.C. Antibody which defines a subset of bone marrow cells that can migrate to thymus. Immunology. 68:1989;59-65.
37. Palacios R., Samaridis J. Thymus colonization in the developing mouse embryo. Eur. J. Immunol. 21:1991;109-113.
38. Poellinger L., Göttlicher M., Gustafsson J.A. The dioxin and peroxisome proliferator-activated receptors: nuclear-receptors nuclear receptors in search of endogenous ligands. TiPS. 13:1992;241-245.
39. Poland A., Glover E. Genetic expression of arylhydrocarbonhydroxylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for a receptor mutation in genetically non-responsive mice. Mol. Pharmacol. 11:1975;389-398.
40. Poland A., Knutson J.C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:1982;517-554.
41. Robey E., Chang D., Itano A., Cado D., Alexander H., Lans D., Weinmaster G., Salmon P. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell. 87:1996;483-492.
42. Ruiz P., Schwärzler C., Günthert U. CD44 isoforms during differentiation and development. Bioessays. 17:1995;17-24.
43. Safe S.H. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Ann. Rev. Pharmacol. Toxicol. 26:1986;371-399.
44. Schmidt J.V., Huei-Ting G., Reddy J.K., Simon M.C., Bradfield C. Characterization of a murine AhR null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. 93:1996;6731-6736.
45. Sewall C.H., Clark G.C., Lucier G.W. TCDD reduces rat hepatic epidermal growth factor receptor: comparison of binding, immunodetection, and autophosphorylation. Toxicol. Appl. Pharmacol. 132:1995;263-272.
46. Staples J.E., Fiore N.C., Frazier D.E. Jr, Gsiewicz T.A., Silverstone A.E. Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 151:1998;200-210.
47. Stauder R., Eisterer W., Thaler J., Günthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood. 85:1995;2885-2899.
48. Sutter T.R., Guzman K., Dold K.M., Greenlee W.F. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science. 254:1991;415-418.
49. Terpe H-J., Störkel S., Zimmer U., Anquez V., Fischer C., Pantel K., Günthert U. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am. J. Pathol. 148:1996;453-463.
50. Vogel C., Abel J. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7. Arch. Toxicol. 69:1995;259-265.
51. Whitlock J.P.J. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu. Rev. Pharmacol. Toxicol. 30:1990;251-277.
52. Wu L., Kincade P.W., Shortman K. The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol. Letters. 38:1993;69-75.